Apple Wins Legal Battle for Blood Oxygen Tracking on Smartwatch
Introduction
In a major victory for Apple Inc., the company has restored the blood oxygen tracking feature on its smartwatch in the US. This comes after a long legal battle, spanning several years, with the tech giant facing challenges in incorporating this technology into its popular device. The feature, which measures the oxygen saturation level in the blood, was initially removed from the US version of the Apple Watch due to FDA regulations. However, with the legal win, Apple is now able to include this highly sought-after feature in their latest smartwatch models.
Key Details
The blood oxygen tracking feature has been available in other countries, such as Canada and the UK, for some time. However, due to strict FDA regulations in the US, Apple was unable to offer this feature to its American customers. The company faced a significant challenge in obtaining approval for the technology, but ultimately emerged victorious in the legal battle. With this feature, users of the Apple Watch can now monitor their blood oxygen levels and receive alerts if they fall below a certain threshold. This is particularly useful for individuals with conditions such as asthma or heart disease, who may need to regularly monitor their oxygen levels.
Impact
This legal win is not only beneficial for Apple, but also for consumers who have been eagerly awaiting this feature on their smartwatches. The ability to track blood oxygen levels can provide valuable insights into one's overall
